Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion type Assertion NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_head.
- NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion description "[Based on multiple epidemiological and immunological studies, which suggest a role of Epstein-Barr virus (EBV) infection in the pathogenesis of MS, we investigated CD21 (CR2, complement receptor type 2), which serves as the EBV receptor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_provenance.
- NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion evidence source_evidence_literature NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_provenance.
- NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion SIO_000772 22137275 NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_provenance.
- NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion wasDerivedFrom befree-20140225 NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_provenance.
- NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_assertion wasGeneratedBy ECO_0000203 NP332727.RALKJUr5JrXJEIe_Yhtt18Zc6n1goWDco7cUZ1nIH4m9A130_provenance.